E-Book | November 6, 2023

Pathways To Bioreactor Process Scaling

Source: Cytiva
Pathways Feature

Bioreactor scaling is the process of translating operating parameters from one bioreactor to another. It is required for cell culture biomanufacturing when advancing a molecule from process development (PD) to commercial manufacturing.

There is a growing market demand for novel molecules and biologics-based therapies beyond traditional monoclonal antibodies - including recombinant proteins, viral vectors, cell- and gene-based therapies, and others - and these advanced therapeutics often require changes to the level of production scale.

The bioreactor scaling process is complex and time-consuming. Digital scaling solutions can help reduce complexities associated with collecting, compiling, and sharing scaling data. Learn more about alternative scaling solutions in this eBook.

access the E-Book!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development